Targets
MDPI AG · Switzerland
eISSN2813-3137
✓ DOAJ✓ Open Access
15
/ 100
High Risk
Score Breakdown
✓ DOAJ Verified+15
Total15
Aims & Scope
Subject areas: Medicine (General). Topics: biological interaction, molecular analysis, drug targeting, targeted therapy, diagnostic biomarkers
General Information
Country / RegionSwitzerland
Primary LanguageEnglish
1st Year Published—
StatusActive
Total Publications—
Publisher OrgMultidisciplinary Digital Publishing Institute
Submission Info
APC Cost$1,000Below median
Peer ReviewAnonymous peer review
Review Time—
Acceptance Rate—
OA LicenseCC BY
OA Rate—
Ethics & Quality
COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Think.Check.Submit Compliance
9/12 · 75%
✅
Do you know the journal / publisher?
✅
Does the journal have a website?
✅
Is the ISSN verified?
✅
Indexed in a trusted database?
✅
Peer review process documented?
❌
Follows ethical publishing standards (COPE)?
✅
APC fees clearly disclosed?
✅
Not on predatory/blacklists?
❌
Long-term digital preservation?
❌
Plagiarism detection in place?
✅
Listed in DOAJ (verified OA)?
✅
Primary language documented?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Advanced biosensing and bioanalysis techniquesComputational Drug Discovery MethodsNanoplatforms for cancer theranosticsLung Cancer Treatments and MutationsRNA Interference and Gene DeliveryMonoclonal and Polyclonal Antibodies ResearchBreast Cancer Treatment StudiesEstrogen and related hormone effectsPI3K/AKT/mTOR signaling in cancerSirtuins and Resveratrol in Medicine
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref